DAIHAN PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28,550 KRW | +0.18% |
|
+0.35% | +2.88% |
| 2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
| 2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Chart calendar Daihan Pharmaceutical Co.,Ltd.
b90318a723784dee96.8WW9D0Z608bvsC70AG5sGqsyhR5hKS1of5NrETZo-UU.vyH2XhkZ5peCgX7HWQgOUdtr4W4mTXccN9oJXwI_vXOQLtM9NE-S9afAHg~2fcfc5838f7373915bb0506555dc21fd
Upcoming events on Daihan Pharmaceutical Co.,Ltd.
Past events on Daihan Pharmaceutical Co.,Ltd.
| 2024-03-19 | Q4 2023 Earnings Release |
| 2023-11-13 | Q3 2023 Earnings Release |
| 2023-08-10 | Q2 2023 Earnings Release |
| 2023-05-14 | Q1 2023 Earnings Release |
| 2023-03-16 | Q4 2022 Earnings Release |
| 2022-11-13 | Q3 2022 Earnings Release |
| 2021-08-16 | Interim 2021 Earnings Release |
| 2021-05-16 | Q1 2021 Earnings Release |
| 2021-02-09 | FY 2020 Earnings Release |
| 2018-08-13 | Interim 2018 Earnings Release |
| 2018-02-05 | FY 2017 Earnings Release |
Past dividends on Daihan Pharmaceutical Co.,Ltd.
| 2023-12-26 | Annual 750 KRW |
| 2022-12-27 | Annual 650 KRW |
| 2021-12-28 | Annual 400 KRW |
| 2020-12-28 | Annual 400 KRW |
| 2019-12-26 | Annual 400 KRW |
| 2018-12-26 | Annual 300 KRW |
| 2017-12-26 | Annual 300 KRW |
| 2016-12-27 | Annual 220 KRW |
| 2015-12-28 | Annual 180 KRW |
| 2014-12-28 | Annual 150 KRW |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 169 168 0.69% | 166 | 171 168 2% | 184 183 0.86% | 196 197 -0.4% | 213 |
|
EBITDA Billions KRW | Released Forecast Spread | 44,4 43,6 1.87% | 41,3 | 40,5 40,8 -0.79% | 42,2 45,6 -7.51% | 44,5 45,0 -1.09% | 47,8 |
|
EBIT Billions KRW | Released Forecast Spread | 33,6 34,7 -3.06% | 30,0 | 29,1 28,5 1.99% | 33,0 32,8 0.51% | 35,8 35,6 0.55% | 38,4 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 37,1 36,7 1.17% | 22,5 | 30,4 30,0 1.44% | 33,5 35,9 -6.82% | 36,7 36,5 0.64% | 39,6 |
|
Net income Billions KRW | Released Forecast Spread | 28,2 27,6 2.05% | 17,4 | 22,7 23,1 -1.86% | 25,0 27,6 -9.56% | 28,4 28,4 0.27% | 30,8 |
|
EPS KRW | Released Forecast Spread | 4 694 4 602 2% | 2 897 | 3 778 3 855 -2% | 4 171 4 597 -9.27% | 4 834 4 730 2.2% | 5 132 |
| Announcement Date | 30/03/20 | 16/03/21 | 09/02/22 | 28/02/23 | 20/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 44,7 42,0 6.42% | 46,4 44,5 4.38% | 48,7 45,9 6.01% | 47,8 46,2 3.55% | 49,7 49,6 0.13% | 50,9 51,5 -1.11% | 49,2 50,2 -1.94% | ||
|
EBIT Billions KRW | Released Forecast Spread | 7,37 6,80 8.41% | 8,35 7,40 12.89% | 9,30 8,70 6.89% | 7,50 7,30 2.73% | 9,12 8,60 6.04% | 9,83 9,80 0.26% | 7,84 7,90 -0.78% | ||
|
Net income Billions KRW | Released Forecast Spread | 6,18 | 6,93 | 7,31 | ||||||
|
EPS KRW | Released Forecast Spread | 1 030 | 1 156 | 1 243 | ||||||
| Announcement Date | 09/02/22 | 16/05/22 | 16/08/22 | 14/11/22 | 28/02/23 | 15/05/23 | 11/08/23 | 14/11/23 | 20/03/24 |
More events
Past sector events for Daihan Pharmaceutical Co.,Ltd.
| Today | SANOFI INDIA LIMITED: Q1 2024 Earnings Release (Projected) |
| 2024-05-06 | SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release |
| 2024-05-02 | HANMI SCIENCE CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-02 10:34 am | PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release |
| 2024-05-02 07:09 am | AJANTA PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-04-29 | SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release |
| 2024-04-29 | KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-29 | OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release |
| 2024-04-29 | BORYUNG CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A023910 Stock
- Calendar Daihan Pharmaceutical Co.,Ltd.